PetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ET
PetVivo Holdings (OTCQX: PETV), a biomedical company focused on innovative medical devices and therapeutics for equines and companion animals, has scheduled its fiscal first quarter 2026 earnings conference call for Thursday, August 14, 2025, at 5:00 p.m. ET.
The company will release its financial results for the quarter ended June 30, 2025, prior to the call. Management will host a presentation followed by a Q&A session. Investors can access the call via toll-free dial-in or webcast, with replay options available through the company's investor relations website.
PetVivo Holdings (OTCQX: PETV), un'azienda biomedica specializzata in dispositivi medici innovativi e terapie per cavalli e animali da compagnia, ha programmato la sua conference call sui risultati del primo trimestre fiscale 2026 per giovedì 14 agosto 2025, alle ore 17:00 ET.
L'azienda pubblicherà i risultati finanziari per il trimestre terminato il 30 giugno 2025 prima della chiamata. La direzione presenterà i dati seguiti da una sessione di domande e risposte. Gli investitori potranno partecipare alla chiamata tramite numero verde o webcast, con opzioni di replay disponibili sul sito web delle relazioni con gli investitori della società.
PetVivo Holdings (OTCQX: PETV), una empresa biomédica centrada en dispositivos médicos innovadores y terapias para equinos y animales de compañía, ha programado su llamada de conferencia de resultados del primer trimestre fiscal 2026 para el jueves 14 de agosto de 2025 a las 5:00 p.m. ET.
La empresa publicará sus resultados financieros del trimestre finalizado el 30 de junio de 2025 antes de la llamada. La gerencia realizará una presentación seguida de una sesión de preguntas y respuestas. Los inversores podrán acceder a la llamada mediante número gratuito o webcast, con opciones de repetición disponibles en el sitio web de relaciones con inversionistas de la compañía.
PetVivo Holdings (OTCQX: PETV)는 말과 반려동물을 위한 혁신적인 의료기기 및 치료법에 중점을 둔 생명공학 회사로, 2026 회계연도 1분기 실적 컨퍼런스 콜을 2025년 8월 14일 목요일 오후 5시(동부시간)에 예정했습니다.
회사는 2025년 6월 30일 종료된 분기의 재무 결과를 콜 전에 발표할 예정입니다. 경영진이 프레젠테이션을 진행한 후 질의응답 시간이 이어집니다. 투자자들은 무료 전화 또는 웹캐스트를 통해 콜에 참여할 수 있으며, 회사 투자자 관계 웹사이트에서 다시보기 옵션도 제공됩니다.
PetVivo Holdings (OTCQX : PETV), une société biomédicale spécialisée dans les dispositifs médicaux innovants et les traitements pour équidés et animaux de compagnie, a programmé sa conférence téléphonique sur les résultats du premier trimestre fiscal 2026 pour le jeudi 14 août 2025 à 17h00 ET.
La société publiera ses résultats financiers pour le trimestre clos le 30 juin 2025 avant la conférence. La direction présentera les résultats, suivie d'une séance de questions-réponses. Les investisseurs pourront accéder à l'appel via un numéro gratuit ou un webcast, avec des options de replay disponibles sur le site des relations investisseurs de la société.
PetVivo Holdings (OTCQX: PETV), ein biomedizinisches Unternehmen, das sich auf innovative medizinische Geräte und Therapien für Pferde und Haustiere spezialisiert hat, hat seine Telefonkonferenz zu den Ergebnissen des ersten Geschäftsquartals 2026 für Donnerstag, den 14. August 2025, um 17:00 Uhr ET angesetzt.
Das Unternehmen wird die Finanzergebnisse für das Quartal zum 30. Juni 2025 vor der Telefonkonferenz veröffentlichen. Das Management wird eine Präsentation halten, gefolgt von einer Fragerunde. Investoren können die Telefonkonferenz über eine gebührenfreie Rufnummer oder einen Webcast verfolgen, mit Wiedergabeoptionen auf der Investor-Relations-Webseite des Unternehmens.
- None.
- None.
MINNEAPOLIS, MN, US, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Thursday, August 14, 2025 at 5:00 p.m. Eastern time to discuss results for the fiscal first quarter ended June 30, 2025. The financial results will be issued in a press release prior to the call.
PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal First Quarter 2026 conference call information is as follows:
Date: Thursday, August 14, 2025
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in number: +1 253 205 0468
Conference ID: 89205449838
Passcode: 680979
Webcast (live and replay): Click Here
A replay of the webcast will be available through the same link following the conference call.
The conference call webcast replay will also be available via a link in the Investors section of the company’s website at petvivo.com/investors.
About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly owned subsidiary, PetVivo Animal Health, Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.
PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead products SPRYNG™ with OsteoCushion™ technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.
For more information about PetVivo Holdings, Inc. and its products please contact info1@petvivo.com or visit https://petvivo.com/, https://www.petvivoanimalhealth.com/ and https://www.sprynghealth.com.
CONTACT:
John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
(952) 405-6216
Forward-Looking Statements:
The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
FAQ
When is PetVivo's (PETV) Q1 2026 earnings call?
How can investors access PetVivo's (PETV) Q1 2026 earnings call?
Where can I find the replay of PetVivo's (PETV) earnings call?
What period will PetVivo's (PETV) earnings report cover?
